Overview
Christopher Hebert is a Nephrologist in Dallas, Texas. Dr. Hebert and is rated as an Experienced provider by MediFind in Angioplasty. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, Stent Placement, and Angioplasty. Dr. Hebert is currently accepting new patients.
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Angioplasty.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Blue Cross Blue Shield
- Aetna
- Friday Health
- Scott and White Health
- Oscar
- Humana
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Ppg Health PA
Saravanan Balamuthusamy is a Nephrologist in Fort Worth, Texas. Dr. Balamuthusamy and is rated as an Advanced provider by MediFind in Angioplasty. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Von Gierke Disease, Angioplasty, and Endoscopy. Dr. Balamuthusamy is currently accepting new patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Experienced
- Acute Tubular Necrosis
- Angioplasty
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Calcinosis
- Calciphylaxis
- D-Plus Hemolytic Uremic Syndrome